Search results
CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics CRSP and Vertex Pharmaceuticals VRTX completed the rolling submission of...
CRISPR (CRSP) Rises More Than 40% in Past 3 Months: Here's Why
Zacks via Yahoo Finance· 6 months agoCRISPR (CRSP) expects a potential approval for its gene-edited therapy, Casgevy (exa-cel) in the...
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
Time via Yahoo News· 2 years agoDr. Jennifer Doudna in Berkeley, Calif., on Jan. 18, 2019. Credit - Anastasiia Sapon—The New York...
CRISPR (CRSP) Shares Rise 24% in the Last Quarter: Here's Why
Zacks via Yahoo Finance· 11 months agoShares of CRISPR (CRSP) surge 24% in the last quarter after the company, along with Vertex, provides...
Could CRISPR cure HIV someday?
Live Science via Yahoo News· 6 months agoClose-up of a gloved hand using tweezers to pull genetic material from a suspended DNA molecule. In an ongoing clinical trial, researchers are testing...
The world's 1st CRISPR therapy has been approved. Here's everything you need to know
Live Science via Yahoo News· 7 months ago3d illustration of sickle-shape blood cells flowing through a blood vessel. The world's first...
Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy
Zacks via Yahoo Finance· 6 months agoVertex Pharmaceuticals Incorporated VRTX announced that the Committee for Medicinal Products for...
FDA approves the first gene-editing treatment in the US
Popular Science via Yahoo News· 6 months agoA researcher handles a petri dish while observing a CRISPR/Cas9 process through a stereomicroscope...
Why CRISPR Therapeutics Stock Charged Northward This Week
Motley Fool· 7 months agoGene therapy stocks have been a bright spot in the market this week. For instance, gene correction...
FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel
Zacks via Yahoo Finance· 12 months agoVertex Pharmaceuticals VRTX and CRISPR Therapeutics CRSP announced that the FDA has accepted their...
